LiverMultiScan® Detected Earlier Stages of Treatable Disease in Patients With Autoimmune Hepatitis to Allow Tailored Treatment - Business Wire

New study with Perspectum’s LiverMultiScan's cT1 measurements found to identify likely disease progression better than blood biomarkers and FibroScan®

OXFORD, England--(BUSINESS WIRE)--A first-of-its-kind study published in eClinicalMedicine - The Lancet, found that LiverMultiScan-cT1 (an MRI-derived non-invasive tissue biomarker), improved autoimm… [+3213 chars]

full article...